Chloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum malaria during an epidemic in Central Java, Indonesia.
A recent malaria epidemic in the Menoreh Hills of Central Java has increased concern about the re-emergence of endemic malaria on Java, which threatens the island's 120 million residents. A 28-day, in-vivo test of the efficacy of treatment of malaria with antimalarial drugs was conducted among...
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2002
|
| _version_ | 1797076884409810944 |
|---|---|
| author | Maguire, J Lacy, MD Sururi Sismadi, P Krisin Wiady, I Laksana, B Bangs, M Masbar, S Susanti, I Basuki, W Barcus, M Marwoto, H Edstein, MD Tjokrosonto, S Baird, J |
| author_facet | Maguire, J Lacy, MD Sururi Sismadi, P Krisin Wiady, I Laksana, B Bangs, M Masbar, S Susanti, I Basuki, W Barcus, M Marwoto, H Edstein, MD Tjokrosonto, S Baird, J |
| author_sort | Maguire, J |
| collection | OXFORD |
| description | A recent malaria epidemic in the Menoreh Hills of Central Java has increased concern about the re-emergence of endemic malaria on Java, which threatens the island's 120 million residents. A 28-day, in-vivo test of the efficacy of treatment of malaria with antimalarial drugs was conducted among 167 villagers in the Menoreh Hills. The treatments investigated, chloroquine (CQ) and sulfadoxine-pyrimethamine (SP), constitute, respectively, the first- and second-line treatments for uncomplicated malaria in Indonesia. The prevalence of malaria among 1389 residents screened prior to enrollment was 33%. Treatment outcomes were assessed by microscopical diagnoses, PCR-based confirmation of the diagnoses, measurement of the whole-blood concentrations of CQ and desethylchloroquine (DCQ), and identification of the Plasmodium falciparum genotypes. The 28-day cumulative incidences of therapeutic failure for CQ and SP were, respectively, 47% (N = 36) and 22% (N = 50) in the treatment of P. falciparum, and 18% (N = 77) and 67% (N = 6) in the treatment of P. vivax. Chloroquine was thus an ineffective therapy for P. falciparum malaria, and the presence of CQ-resistant P. vivax and SP-resistant P. falciparum will further compromise efforts to control resurgent malaria on Java. |
| first_indexed | 2024-03-07T00:10:00Z |
| format | Journal article |
| id | oxford-uuid:78e8a329-ee5b-46ff-8374-866a1af20810 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T00:10:00Z |
| publishDate | 2002 |
| record_format | dspace |
| spelling | oxford-uuid:78e8a329-ee5b-46ff-8374-866a1af208102022-03-26T20:33:49ZChloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum malaria during an epidemic in Central Java, Indonesia.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:78e8a329-ee5b-46ff-8374-866a1af20810EnglishSymplectic Elements at Oxford2002Maguire, JLacy, MDSururiSismadi, PKrisinWiady, ILaksana, BBangs, MMasbar, SSusanti, IBasuki, WBarcus, MMarwoto, HEdstein, MDTjokrosonto, SBaird, JA recent malaria epidemic in the Menoreh Hills of Central Java has increased concern about the re-emergence of endemic malaria on Java, which threatens the island's 120 million residents. A 28-day, in-vivo test of the efficacy of treatment of malaria with antimalarial drugs was conducted among 167 villagers in the Menoreh Hills. The treatments investigated, chloroquine (CQ) and sulfadoxine-pyrimethamine (SP), constitute, respectively, the first- and second-line treatments for uncomplicated malaria in Indonesia. The prevalence of malaria among 1389 residents screened prior to enrollment was 33%. Treatment outcomes were assessed by microscopical diagnoses, PCR-based confirmation of the diagnoses, measurement of the whole-blood concentrations of CQ and desethylchloroquine (DCQ), and identification of the Plasmodium falciparum genotypes. The 28-day cumulative incidences of therapeutic failure for CQ and SP were, respectively, 47% (N = 36) and 22% (N = 50) in the treatment of P. falciparum, and 18% (N = 77) and 67% (N = 6) in the treatment of P. vivax. Chloroquine was thus an ineffective therapy for P. falciparum malaria, and the presence of CQ-resistant P. vivax and SP-resistant P. falciparum will further compromise efforts to control resurgent malaria on Java. |
| spellingShingle | Maguire, J Lacy, MD Sururi Sismadi, P Krisin Wiady, I Laksana, B Bangs, M Masbar, S Susanti, I Basuki, W Barcus, M Marwoto, H Edstein, MD Tjokrosonto, S Baird, J Chloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum malaria during an epidemic in Central Java, Indonesia. |
| title | Chloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum malaria during an epidemic in Central Java, Indonesia. |
| title_full | Chloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum malaria during an epidemic in Central Java, Indonesia. |
| title_fullStr | Chloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum malaria during an epidemic in Central Java, Indonesia. |
| title_full_unstemmed | Chloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum malaria during an epidemic in Central Java, Indonesia. |
| title_short | Chloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum malaria during an epidemic in Central Java, Indonesia. |
| title_sort | chloroquine or sulfadoxine pyrimethamine for the treatment of uncomplicated plasmodium falciparum malaria during an epidemic in central java indonesia |
| work_keys_str_mv | AT maguirej chloroquineorsulfadoxinepyrimethamineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaduringanepidemicincentraljavaindonesia AT lacymd chloroquineorsulfadoxinepyrimethamineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaduringanepidemicincentraljavaindonesia AT sururi chloroquineorsulfadoxinepyrimethamineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaduringanepidemicincentraljavaindonesia AT sismadip chloroquineorsulfadoxinepyrimethamineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaduringanepidemicincentraljavaindonesia AT krisin chloroquineorsulfadoxinepyrimethamineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaduringanepidemicincentraljavaindonesia AT wiadyi chloroquineorsulfadoxinepyrimethamineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaduringanepidemicincentraljavaindonesia AT laksanab chloroquineorsulfadoxinepyrimethamineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaduringanepidemicincentraljavaindonesia AT bangsm chloroquineorsulfadoxinepyrimethamineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaduringanepidemicincentraljavaindonesia AT masbars chloroquineorsulfadoxinepyrimethamineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaduringanepidemicincentraljavaindonesia AT susantii chloroquineorsulfadoxinepyrimethamineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaduringanepidemicincentraljavaindonesia AT basukiw chloroquineorsulfadoxinepyrimethamineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaduringanepidemicincentraljavaindonesia AT barcusm chloroquineorsulfadoxinepyrimethamineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaduringanepidemicincentraljavaindonesia AT marwotoh chloroquineorsulfadoxinepyrimethamineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaduringanepidemicincentraljavaindonesia AT edsteinmd chloroquineorsulfadoxinepyrimethamineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaduringanepidemicincentraljavaindonesia AT tjokrosontos chloroquineorsulfadoxinepyrimethamineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaduringanepidemicincentraljavaindonesia AT bairdj chloroquineorsulfadoxinepyrimethamineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaduringanepidemicincentraljavaindonesia |